• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchEQRx
    Picture of EQRx logo

    EQRX — EQRx Share News

    $2.340.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid Cap
    • Market Cap
      $1.14bn
    • Enterprise Value
      -$71.09m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • EQRX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    EQRX Dividends
    • Keith Meister-backed SPAC to merge with biotech firm EQRx in $3.65 bln deal (updated)

      06/08/2021 12:21
    • Keith Meister, Eli Casdin's third SPAC to merge with biotech EQRx

      06/08/2021 12:03
    • NASDAQ TRADE HALT HALT NEWS DISSEMINATION AT 07:00 AM

      06/08/2021 12:01
    • NASDAQ TRADE HALT HALT NEWS DISSEMINATION AT 07:00 AM

      06/08/2021 12:01
    • NASDAQ TRADE HALT HALT NEWS DISSEMINATION AT 07:00 AM

      06/08/2021 12:01
    • Brief: SPAC Backed By Corvex, Casdin Near Deal For Drug-Price Startup EQRx - WSJ

      06/08/2021 11:07
    Previous123Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.